(PharmaNewsWire.Com, July 15, 2021 ) In vitro diagnostics quality control are tests which used to detect infection, disease and different conditions. Some of these tests are used for health professional settings and others are used in the laboratory and some tests are used for consumers to use at home. In vitro diagnostics quality control includes medical accessories and devices used to perform tests on samples such as tissue, urine , blood which laken from the person's body in order to monitor drug therapies, prevent disease, diagnose a medical condition and help detect infection. In vitro diagnostics quality control devices can range from simple tests to sophisticated DNA technology such as software, kits, control materials, calibrators, reagents and related instruments.
In vitro diagnostics quality control market are segmented on the basis of product & service, application, manufacturer, end user and region. On the basis of product & service the market is segmented into Quality Control Products, Serum/Plasma-Based Controls, Whole Blood-Based Controls, Urine-Based Controls, Other Source-Based IVD Quality Controls, Data Management Solutions and Quality Assurance Services. Based on application the market is divided into Immunochemistry/Immunoassay, Clinical Chemistry, Hematology, Molecular Diagnostics, Coagulation & Hemostasis, Microbiology and Other Applications. On lines of manufacture the market is segregated into Third-Party Control Manufacturers, Independent Controls, Instrument-Specific Controls and Original Equipment Manufacturers (OEMS). In vitro diagnostics quality control market is segmented into on the basis of end users are Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End Users.
The major key players in the global in vitro diagnostics quality control market includes Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), SeraCare Life Sciences Inc. (US), Abbott Laboratories Inc. (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics, Inc. (US), and Helena Laboratories (US).
Report Table Of Content
1. In Vitro Diagnostics Quality Control Market Introduction
1.1. Key Insights
1.2. Report Overview
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.4. Market Size Estimation
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Drivers and Restraints
5. In Vitro Diagnostics Quality Market, By Product & Service
We are a growth partnership company that provides fact-based consulting services focused on helping our clients achieve incremental and transformational growth competing in business-to- business and business-to- consumer markets. We facilitate their growth journey through an environment that is dominated by accelerating change, constant evolution of new business models, disruptive trends and technologies in their respective industry.
We serve a wide spectrum of global industries such as Semiconductor and Electronics, Information Technology, Communication, Medical Devices, Pharmaceuticals, Defense, Aviation, and Chemicals among others. Our well-seasoned blend of technical and marketing expertise enables us to serve our customers with comprehensive study of global supply chains that helps them to devise highly effective strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
